# GlaxoSmithKline Biologicals SA – FDA Inspection, Feb 27, 2026

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/a73f4473-48f2-4d60-ada1-1284eeb61f46
Source feed: FDA_Inspections

> FDA inspection 1305486 of GlaxoSmithKline Biologicals SA, February 27, 2026. 6 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1305486
- Company Name: GlaxoSmithKline Biologicals SA
- Inspection Date: 2026-02-27
- Project Area: Vaccine, Allergenic, and Live Biotherapeutic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Office of Inspections and Investigations
- Citation Count: 6

## Related Documents

- FDA Inspection 1214970 - 2023-06-23
- [FDA Inspection 1099401 - 2019-06-24](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/c59f4d26-ddd7-4e65-b71c-2b9e086c0932)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/shafiq-s-ahadi/dd146b0a-ca1c-4052-8f50-4d68e14ad73f)
- [FDA Associated Person](https://www.keypedia.com/people/thai-d-truong/7395c128-0adb-44a1-8831-64673c98e93d)

Company: https://www.keypedia.com/companies/glaxosmithkline-biologicals-sa/9a234513-4162-49b8-b149-5c1be5aa9090

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
